Stage IV Lymphoepithelioma of the Nasopharynx Completed Phase 3 Trials for Amifostine (DB01143)

IndicationStatusPhase
DBCOND0029528 (Stage IV Lymphoepithelioma of the Nasopharynx)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00274937Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal CancerTreatment